Type 2 Diabetes Remission: What It Means and Why It Is Not a Cure

If you or someone close to you has been diagnosed with Type 2 diabetes, you may have come across the word 'remission' in a GP appointment, a Diabetes UK leaflet, or an online search late at night. It sounds hopeful — and it should, because for some people, remission is genuinely achievable. But the word also raises questions. Does remission mean the diabetes has gone? Can it come back? Is it safe to stop medication?

This article explains what Type 2 diabetes remission actually means according to the current medical consensus, why it is not the same as a cure, and why ongoing monitoring remains important even when blood sugar levels have returned to a healthy range.

What is Type 2 diabetes remission?

In 2021, an international expert group convened by the American Diabetes Association, the European Association for the Study of Diabetes, Diabetes UK and the Endocrine Society published a joint consensus report defining remission for the first time in a standardised way.

Their agreed definition is straightforward. A person with Type 2 diabetes is considered to be in remission when their HbA1c — a blood test that reflects average blood glucose over the previous two to three months — falls below 48 mmol/mol (6.5%) and stays there for at least three months after stopping all glucose-lowering medication.

The expert group chose the word 'remission' deliberately. They did not use 'reversal', and they specifically advised against using the word 'cure'. Remission means the condition is no longer active — but the underlying susceptibility has not disappeared.

What is HbA1c and why does it matter?

HbA1c (glycated haemoglobin) measures the percentage of red blood cells that have glucose attached to them. Because red blood cells live for roughly two to three months, HbA1c gives a longer-term picture than a single finger-prick glucose reading.

In the UK, HbA1c is measured in millimoles per mole (mmol/mol). The diagnostic threshold for Type 2 diabetes is 48 mmol/mol (6.5%) or above. A reading between 42 and 47 mmol/mol indicates a higher risk of developing diabetes but does not meet the diagnostic threshold.

For remission to be confirmed, HbA1c must remain below 48 mmol/mol for at least three months without glucose-lowering medication. A single reading below the threshold is not enough — the improvement needs to be sustained.

Why remission is not the same as cure

This is perhaps the most important distinction to understand. A cured condition has gone permanently. Remission means the condition is not currently active, but the risk of recurrence remains.

Several factors explain why Type 2 diabetes can return after a period of remission. The genetic susceptibility that contributed to its development has not changed. Weight regain — even a moderate amount — can re-trigger insulin resistance. Beta-cell function in the pancreas may continue to decline over time, regardless of lifestyle changes. Stress, illness, certain medications, and the natural ageing process can all push blood glucose levels back above the diagnostic threshold.

Research from the DiRECT trial — a landmark UK primary care study — illustrates this clearly. At one year, 46% of intervention participants achieved remission. At two years, this had reduced to 36%. By five years, 13% remained in remission, though those who maintained their weight loss had substantially better outcomes. This does not diminish the value of remission — it reinforces why it needs to be understood as an ongoing achievement rather than a one-off event.

Why blood glucose can return to the diabetes range

Weight regain is the most well-documented factor associated with recurrence. In the DiRECT trial, participants who regained weight between their first and second year were more likely to lose their remission status. This makes sense physiologically: excess fat — particularly visceral fat around the liver and pancreas — drives insulin resistance, and when that fat returns, so does the metabolic burden.

But weight is not the only factor. Beta-cell exhaustion is progressive in many people with Type 2 diabetes, meaning the pancreas gradually produces less insulin over time. Even with sustained weight loss, this decline may eventually push blood glucose above the remission threshold. Longer duration of diabetes before achieving remission is also associated with a higher risk of recurrence, likely because beta-cell damage is more advanced.

Why ongoing diabetes checks remain essential

The 2021 consensus report was clear on this point: people in remission should continue to receive the same routine diabetes monitoring as those with active Type 2 diabetes. This includes regular HbA1c testing (at least annually), retinal screening, kidney function tests, blood pressure checks, foot assessments, and cardiovascular risk review.

There are good reasons for this. Microvascular complications — damage to the small blood vessels in the eyes, kidneys and nerves — can continue to progress even during remission. In some cases, a rapid reduction in blood glucose after a long period of poor control can temporarily worsen retinopathy. The consensus group specifically warned that if retinopathy is already present beyond simple microaneurysms, blood glucose should not be reduced too quickly, and retinal screening should be repeated if a rapid decline is observed.

Remission does not mean discharge from diabetes care. It means the condition is being managed well enough that medication is not currently needed.

Why nobody should stop medication independently

This point cannot be overstated. Stopping diabetes medication without medical supervision is dangerous. Medication doses need to be adjusted gradually, under the guidance of a GP or prescribing clinician, with regular blood glucose monitoring throughout the process.

Abruptly stopping medication — particularly insulin or sulfonylureas — can cause either dangerously high or dangerously low blood sugar, depending on the circumstances. Even when lifestyle changes are producing excellent results, the timing and sequence of medication reduction must be managed by someone qualified to do so.

If you are making lifestyle changes that are improving your blood glucose levels, speak to your GP or diabetes nurse about reviewing your medication. Do not adjust doses yourself.

Remission is possible for some people — but cannot be guaranteed

Evidence from clinical trials suggests that meaningful weight loss — particularly when achieved relatively soon after diagnosis — gives some people the best chance of achieving remission. The DiRECT trial focused on adults with a diabetes duration of less than six years and a BMI between 27 and 45, and found that structured weight management in primary care could produce clinically significant remission rates.

However, not everyone who makes lifestyle changes will achieve remission, and that is not a failure. Improved blood glucose management, reduced cardiovascular risk, better energy levels, and improved quality of life are all meaningful outcomes — whether or not the HbA1c falls below the remission threshold. Better management of Type 2 diabetes is always worthwhile, even when full remission is not achieved.

The factors that influence whether remission is achievable include how long someone has had diabetes, how much beta-cell function remains, their starting weight and body composition, genetic factors, and the degree of lifestyle change they are able to sustain.

Where eMedicard fits

eMedicard's Type 2 Diabetes programme is a clinician-led lifestyle intervention designed to support eligible adults in improving their metabolic health. The programme combines personalised nutrition guidance with daily monitoring and clinical oversight, with the aim of supporting participants toward better diabetes management and, where appropriate, working toward remission under medical supervision.

Remission is not guaranteed, and the programme is not suitable for everyone. Eligibility depends on individual clinical circumstances. If you would like to discuss whether a structured lifestyle programme could be appropriate for your situation, you can book a free consultation with the eMedicard team.

Frequently asked questions

What HbA1c level counts as remission?
According to the 2021 international consensus, remission is defined as an HbA1c below 48 mmol/mol (6.5%) sustained for at least three months after stopping all glucose-lowering medication.

Can Type 2 diabetes come back after remission?
Yes. Remission is not permanent. Blood glucose can return to the diabetes range due to weight regain, progressive beta-cell decline, stress, illness, or other factors. Ongoing monitoring is essential.

Is remission the same as reversal?
The international consensus group chose 'remission' rather than 'reversal' or 'cure' because it accurately reflects that the improvement may not be permanent and requires ongoing surveillance. The terms are sometimes used interchangeably in everyday language, but clinically, 'remission' is the preferred and more precise term.

Should I stop taking my medication if my blood sugar improves?
No — never stop or change your medication without speaking to your GP or prescribing clinician. Medication adjustments must be made gradually and under medical supervision.

Does everyone with Type 2 diabetes have a chance of remission?
Remission is more likely for some people than others. Factors include how long since diagnosis, remaining beta-cell function, starting weight, and the degree of lifestyle change achieved. Even when remission is not reached, improved blood glucose management has real health benefits.

Medical disclaimer: This article is for general information only and does not constitute personal medical advice. Individual circumstances vary. Please consult a qualified healthcare professional before making changes to your diet, exercise, medication or treatment plan.